REAP Financial Group’s Zimmer Biomet ZBH Stock Holding History

REAP Financial Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54	Closed	-$6.58K	–	683
2023 Q4	$6.58K	Buy	+54	New	+$6.03K	﹤0.01%	442

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

REAP Financial Group's ZBH Position: Q1 2024 in Review

REAP Financial Group sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 54 shares — an estimated $6.58K sold.

REAP Financial Group first reported a position in ZBH in Q4 2023 and held it in 1 quarter. The position peaked at $6.58K in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

REAP Financial Group reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
REAP Financial Group sold 54 Zimmer Biomet shares in Q1 2024, an estimated $6.58K.
REAP Financial Group first reported a position in Zimmer Biomet in Q4 2023 and held it in 1 quarter.
REAP Financial Group's Zimmer Biomet position peaked at $6.58K in Q4 2023.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on REAP Financial Group's 13F filing for Q1 2024, filed 27 Feb 2025.